InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2026-03-11 | Zamore Denise | Chief Legal Officer | Purchase | 5,535 | — | — | 448.7K | View ↗ | |
| 2026-03-09 | 2026-03-11 | Venkatachaliah Girish | Chief Technology Officer | Purchase | 18.4K | — | — | 285.1K | View ↗ | |
| 2026-03-02 | 2026-03-03 | Shaker Benjamin | Chief Markets Officer | Purchase | 500.0K | $0.60 | $301K | 1.37M | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenues | $11.2M-12.3% | $12.8M+42.2% | $9.0M+170.6% | $3.3M+5.0% | $3.2M |
| General and administrative | $238.5M-11.3% | $268.9M-5.9% | $285.8M+37.5% | $207.8M | — |
| Depreciation and amortization | $28.6M+16.9% | $24.5M+52.5% | $16.0M+79.3% | $8.9M-14.6% | $10.5M |
| Impairments | $36.1M+903.5% | $3.6M | $0 | $0 | — |
| Total expenses | $6.40B+0.7% | $6.35B+39.7% | $4.55B+82.4% | $2.49B+31.7% | $1.89B |
| Income (loss) from operations | -$463.2M-58.6% | -$292.1M-25.8% | -$232.1M-120.3% | -$105.4M+71.7% | -$372.2M |
| Income (loss) from equity method investments | -$1.8M-112.2% | $15.0M-9.1% | $16.5M+53.8% | $10.7M+258.4% | -$6.8M |
| Other income (expense), net | $67.6M+96.1% | $34.5M+23.9% | $27.8M+99.9% | $13.9M+539.6% | $2.2M |
| Interest expense | -$6.6M-7.5% | -$6.2M+7.2% | -$6.7M-48.5% | -$4.5M+27.0% | -$6.1M |
| Income (loss) before income taxes | -$404.1M-62.4% | -$248.8M-28.0% | -$194.5M-114.5% | -$90.7M+76.3% | -$383.0M |
| Income tax benefit (expense) | -$1.3M+13.8% | -$1.5M-83.4% | -$791K-2942.3% | -$26K-101.5% | $1.7M |
| Income (loss) from continuing operations | -$405.3M-62.0% | -$250.3M-28.2% | -$195.3M-111.5% | -$92.3M+76.0% | -$383.9M |
| Income (loss) before gain (loss) on sales | $0+100.0% | -$1.1M+94.7% | -$20.0M | — | — |
| Gain (loss) and adjustments on sales of assets, net | $14.0M+259.8% | -$8.8M+81.6% | -$47.5M | — | — |
| Total discontinued operations | $14.0M+242.5% | -$9.8M+85.5% | -$67.5M-364.1% | -$14.6M+36.5% | -$22.9M |
| Net income (loss) | -$391.3M-50.5% | -$260.1M+1.0% | -$262.8M-145.9% | -$106.9M+73.7% | -$406.8M |
| Noncontrolling interests’ share in (earnings) loss | $0+100.0% | -$50K-124.2% | $207K-33.4% | $311K+3.7% | $300K |
| Net income (loss) attributable to common shares | -$391.3M-50.4% | -$260.2M+0.9% | -$262.6M-146.4% | -$106.6M+73.8% | -$406.5M |
| Continuing operations basic (in dollars per share) | -$980-60.7% | -$610-27.1% | -$480-118.2% | -$220+78.6% | -$1K |
| Continuing operations diluted (in dollars per share) | -$980-60.7% | -$610-27.1% | -$480-118.2% | -$220+78.6% | -$1K |
| Discontinued operations basic (in dollars per share) | $30+250.0% | -$20+87.5% | -$160-300.0% | -$40+33.3% | -$60 |
| Discontinued operations diluted (in dollars per share) | $30+250.0% | -$20+87.5% | -$160-300.0% | -$40+33.3% | -$60 |
| Weighted average shares outstanding, basic (in shares) | $414.0M+0.7% | $411.0M+0.5% | $408.9M+0.2% | $408.2M+9.4% | $372.9M |
| Weighted average shares outstanding, diluted (in shares) | $414.0M+0.7% | $411.0M+0.5% | $408.9M+0.2% | $408.2M+9.4% | $372.9M |
| Medical services revenue | |||||
| Total revenues | $11.2M-12.3% | $12.8M+42.2% | $9.0M+170.6% | $3.3M+5.0% | $3.2M |
| Expenses | $114.7M-46.2% | $213.2M-10.5% | $238.0M+30.1% | $183.0M+85.9% | $98.4M |
| Other operating revenue | |||||
| Total revenues | $11.2M-12.3% | $12.8M+42.2% | $9.0M+170.6% | $3.3M+5.0% | $3.2M |
| Expenses | $114.7M-46.2% | $213.2M-10.5% | $238.0M+30.1% | $183.0M+85.9% | $98.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Agilon health forecasts $5.7B 2026 revenue as it raises outlook after Q1 outperformance
agilon health, inc. (AGL) Q1 2026 Earnings Call Transcript
Agilon Health (AGL) Q1 Earnings and Revenues Top Estimates
agilon health (AGL) Q1 2026 Earnings Transcript